You are here

investors

With just a little encouragement, biotech investors are ready to fall in love again

With just a little encouragement, biotech investors are ready to fall in love again

Endpoints

Flag link:

Gilead Sciences' Kite Pharma Deal Has Already Paid for Itself -- for Investors

Gilead Sciences' Kite Pharma Deal Has Already Paid for Itself -- for Investors

Motley Fool

Gilead Sciences

Flag link:

Activist investor pushing for Acorda sale

Activist investor pushing for Acorda sale

BioPharma Dive

Flag link:

The 1 Word in GW Pharmaceuticals' Q3 Update That Disappointed Investors

The 1 Word in GW Pharmaceuticals' Q3 Update That Disappointed Investors

Motley Fool

Flag link:

MannKind: Afrezza Television Ad Debuts; What Investors Need To Know

MannKind: Afrezza Television Ad Debuts; What Investors Need To Know

Seeking Alpha

inhaled insulin

Flag link:

Forget the science. These investors think they can pick biotech winners by algorithm

Forget the science. These investors think they can pick biotech winners by algorithm

Stat

venture capital

Flag link:

3 Surprising Reasons Drug Stocks Tank Every Time the Republican Health Bill Hits a Snag

3 Surprising Reasons Drug Stocks Tank Every Time the Republican Health Bill Hits a Snag

Motley Fool

healthcare reform

Flag link:

Investors — and AstraZeneca CEO Pascal Soriot — are getting a tad nervous as MYSTIC data loom

Investors — and AstraZeneca CEO Pascal Soriot — are getting a tad nervous as MYSTIC data loom

Endpoints

immuno-oncology

clinical trials

Flag link:

Mylan, embattled maker of EpiPen, faces a crucial test as angry investors plot to oust CEO

Mylan, embattled maker of EpiPen, faces a crucial test as angry investors plot to oust CEO

Stat

Flag link:

Investors are being told to go scorched earth on the company that makes EpiPen

Investors are being told to go scorched earth on the company that makes EpiPen

Yahoo/Business Insider

Flag link:

Pfizer investors slam new price increases as 'out of step’ with its Big Pharma rivals

Pfizer investors slam new price increases as 'out of step’ with its Big Pharma rivals

Fierce Pharma

Flag link:

What Valeant Pharmaceuticals' Latest Sale Means (and Doesn't Mean) for Investors

What Valeant Pharmaceuticals' Latest Sale Means (and Doesn't Mean) for Investors

Motley Fool

Valeant Pharmaceuticals

Flag link:

An anonymous blogger angers biotech investors. But are his posts illegal?

An anonymous blogger angers biotech investors. But are his posts illegal?

Bizjournals.com

Flag link:

U.S. medtech shares gain as investors seek shelter from drug price debate

U.S. medtech shares gain as investors seek shelter from drug price debate

Yahoo/Reuters

Flag link:

5 biotech CEOs on payers, investors and big bets

5 biotech CEOs on payers, investors and big bets

BioPharma Dive

Gil Van Bokkelen

DalCor Pharmaceuticals

Pierre Belichard

Michael Metzger

Flag link:

Drugmakers fall as investors see pricing threat from Trump

Drugmakers fall as investors see pricing threat from Trump

Yahoo/AP

Flag link:

Investors in big pharma, biotech look to ride out Trump storm

Investors in big pharma, biotech look to ride out Trump storm

Yahoo/Reuters

Flag link:

What Biotech Investors Can Expect From the J.P. Morgan Healthcare Conference 2017

What Biotech Investors Can Expect From the J.P. Morgan Healthcare Conference 2017

TheStreet.com

Flag link:

Hedge Fund Investor Sues Theranos For Lying 'Knowingly And Repeatedly'

Hedge Fund Investor Sues Theranos For Lying 'Knowingly And Repeatedly'

Forbes

Flag link:

Did Pfizer's No-Split Decision Cost Investors a Lot of Money?

Did Pfizer's No-Split Decision Cost Investors a Lot of Money?

Investopedia

Flag link: